IO Biotech Inc (IOBT)
1.39
-0.01
(-0.71%)
USD |
NASDAQ |
May 17, 16:00
1.39
0.00 (0.00%)
After-Hours: 20:00
IO Biotech Cash from Investing (TTM): -0.186M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.186M |
| December 31, 2023 | -0.323M |
| September 30, 2023 | -0.56M |
| June 30, 2023 | -0.654M |
| March 31, 2023 | -0.722M |
| Date | Value |
|---|---|
| December 31, 2022 | -0.69M |
| September 30, 2022 | -0.491M |
| June 30, 2022 | -0.376M |
| March 31, 2022 | -0.269M |
| December 31, 2021 | -0.153M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.722M
Minimum
Mar 2023
-0.153M
Maximum
Dec 2021
-0.4424M
Average
-0.4335M
Median
Cash from Investing (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.062M |
| Palatin Technologies Inc | 9.41M |
| iBio Inc | 8.285M |
| Theriva Biologics Inc | -0.194M |
| Oragenics Inc | -0.9363M |